Thrombocytosis and megakaryocyte changes associated with PRCA
Blood Adv
.
2024 Jun 25;8(12):3058-3062.
doi: 10.1182/bloodadvances.2023012309.
Authors
Joelle Abdallah
1
,
Robert George Williams
1
,
Hussein Awada
2
,
Ganesh Raman
1
,
Yusuf Ozcan
3
,
Mark Orland
2
,
Mutlu Mete
4
,
Weina Chen
5
,
Carmelo Gurnari
2
6
,
Jaroslaw P Maciejewski
2
,
Taha Bat
1
Affiliations
1
Division of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.
2
Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH.
3
University of Texas Dallas, Dallas TX.
4
Department of Computer Science, Texas A&M University-Commerce, Commerce, TX.
5
Department of Pathology, UT Southwestern Medical Center, Dallas, TX.
6
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
PMID:
38564765
PMCID:
PMC11215193
DOI:
10.1182/bloodadvances.2023012309
No abstract available
MeSH terms
Humans
Megakaryocytes* / cytology
Megakaryocytes* / metabolism
Megakaryocytes* / pathology
Myeloproliferative Disorders / pathology
Thrombocytosis* / etiology
Thrombocytosis* / pathology